Literature DB >> 27166649

Transgenic bovine as bioreactors: Challenges and perspectives.

Paulo S Monzani1,2, Paulo R Adona1, Otávio M Ohashi3, Flávio V Meirelles2, Matthew B Wheeler4.   

Abstract

The use of recombinant proteins has increased in diverse commercial sectors. Various systems for protein production have been used for the optimization of production and functional protein expression. The mammary gland is considered to be a very interesting system for the production of recombinant proteins due to its high level of expression and its ability to perform post-translational modifications. Cows produce large quantities of milk over a long period of lactation, and therefore this species is an important candidate for recombinant protein expression in milk. However, transgenic cows are more difficult to generate due to the inefficiency of transgenic methodologies, the long periods for transgene detection, recombinant protein expression and the fact that only a single calf is obtained at the end of each pregnancy. An increase in efficiency for transgenic methodologies for cattle is a big challenge to overcome. Promising methodologies have been proposed that can help to overcome this obstacle, enabling the use of transgenic cattle as bioreactors for protein production in milk for industry.

Entities:  

Keywords:  bioreactor; mammary gland; milk protein; recombinant protein; transgenesis methodologies; transgenic bovine

Mesh:

Substances:

Year:  2016        PMID: 27166649      PMCID: PMC4927206          DOI: 10.1080/21655979.2016.1171429

Source DB:  PubMed          Journal:  Bioengineered        ISSN: 2165-5979            Impact factor:   3.269


  51 in total

Review 1.  Generation of germ cells in vitro in the era of induced pluripotent stem cells.

Authors:  Masanori Imamura; Orie Hikabe; Zachary Yu-Ching Lin; Hideyuki Okano
Journal:  Mol Reprod Dev       Date:  2013-09-30       Impact factor: 2.609

2.  Generation of transgenic porcine chimeras using primordial germ cell-derived colonies.

Authors:  J A Piedrahita; K Moore; B Oetama; C K Lee; N Scales; J Ramsoondar; F W Bazer; T Ott
Journal:  Biol Reprod       Date:  1998-05       Impact factor: 4.285

3.  Production of live calves derived from embryonic stem-like cells aggregated with tetraploid embryos.

Authors:  S Iwasaki; K H Campbell; C Galli; K Akiyama
Journal:  Biol Reprod       Date:  2000-02       Impact factor: 4.285

4.  Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts.

Authors:  A E Schnieke; A J Kind; W A Ritchie; K Mycock; A R Scott; M Ritchie; I Wilmut; A Colman; K H Campbell
Journal:  Science       Date:  1997-12-19       Impact factor: 47.728

5.  Production of transgenic rabbits, sheep and pigs by microinjection.

Authors:  R E Hammer; V G Pursel; C E Rexroad; R J Wall; D J Bolt; K M Ebert; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

6.  Construction of a recombinant human insulin expression vector for mammary gland-specific expression in buffalo (Bubalus bubalis) mammary epithelial cell line.

Authors:  Ramakant Kaushik; Karn Pratap Singh; Archana Kumari; K Rameshbabu; Manoj Kumar Singh; Radhey Shyam Manik; Prabhat Palta; Suresh Kumar Singla; Manmohan Singh Chauhan
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

7.  Breeding of transgenic cattle for human coagulation factor IX by a combination of lentiviral system and cloning.

Authors:  P S Monzani; J R Sangalli; T H C De Bem; F F Bressan; P Fantinato-Neto; J R V Pimentel; E H Birgel-Junior; A M Fontes; D T Covas; F V Meirelles
Journal:  Genet Mol Res       Date:  2013-02-28

Review 8.  Transposon-mediated genome manipulation in vertebrates.

Authors:  Zoltán Ivics; Meng Amy Li; Lajos Mátés; Jef D Boeke; Andras Nagy; Allan Bradley; Zsuzsanna Izsvák
Journal:  Nat Methods       Date:  2009-06       Impact factor: 28.547

9.  Germline transgenesis in rabbits by pronuclear microinjection of Sleeping Beauty transposons.

Authors:  Zoltán Ivics; László Hiripi; Orsolya I Hoffmann; Lajos Mátés; Tien Yin Yau; Sanum Bashir; Vaclav Zidek; Vladimír Landa; Aron Geurts; Michal Pravenec; Thomas Rülicke; Zsuzsanna Bösze; Zsuzsanna Izsvák
Journal:  Nat Protoc       Date:  2014-03-13       Impact factor: 13.491

10.  Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin.

Authors:  Penghua Yang; Jianwu Wang; Guochun Gong; Xiuzhu Sun; Ran Zhang; Zhuo Du; Ying Liu; Rong Li; Fangrong Ding; Bo Tang; Yunping Dai; Ning Li
Journal:  PLoS One       Date:  2008-10-20       Impact factor: 3.240

View more
  6 in total

Review 1.  Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development.

Authors:  Nagesh K Tripathi; Ambuj Shrivastava
Journal:  Front Bioeng Biotechnol       Date:  2019-12-20

2.  Characterization of the regulatory 5'-flanking region of bovine mucin 2 (MUC2) gene.

Authors:  Melissa Shizue de Almeida Yamashita; Luna Nascimento Vargas; Eduardo de Oliveira Melo
Journal:  Mol Cell Biochem       Date:  2021-03-17       Impact factor: 3.396

Review 3.  Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era.

Authors:  Birbal Singh; Gorakh Mal; Vinod Verma; Ruchi Tiwari; Muhammad Imran Khan; Ranjan K Mohapatra; Saikat Mitra; Salem A Alyami; Talha Bin Emran; Kuldeep Dhama; Mohammad Ali Moni
Journal:  Stem Cell Res Ther       Date:  2021-05-12       Impact factor: 6.832

4.  Expression of a triple mutational des-pGlu brazzein in transgenic mouse milk.

Authors:  Rui Lu; Xiaoming Li; Jian Hu; Yong Zhang; Yancui Wang; Le Jin
Journal:  FEBS Open Bio       Date:  2022-05-03       Impact factor: 2.792

Review 5.  Development of genome engineering technologies in cattle: from random to specific.

Authors:  Soo-Young Yum; Ki-Young Youn; Woo-Jae Choi; Goo Jang
Journal:  J Anim Sci Biotechnol       Date:  2018-01-30

Review 6.  Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.

Authors:  Tharmala Tharmalingam; Xiaobing Han; Ashley Wozniak; Laura Saward
Journal:  Hum Vaccin Immunother       Date:  2021-05-19       Impact factor: 4.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.